Last 12 months
Inside the activity.
0 purchase rows · 169 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 23 |
| Dec 2025 | 0 | 18 |
| Jan 2026 | 0 | 44 |
| Feb 2026 | 0 | 22 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 19 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2021 Filed Mar 12, 2021 21:10 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
Exercise / conversionCommon Stock | 4,709 | $20.49 | $96,487.41 |
DisclosureSEC source: 0001140361-21-008313 · form4.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,629 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:09 UTC |
ENGELSEN STEINAR JDirector
|
PurchaseCommon Stock | 2,710 | $36.90 | $99,999.00 |
DisclosureSEC source: 0001140361-21-007636 · form4.xml · nonDerivative · entry 1 ENGELSEN STEINAR J · CIK 0001218860 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,009 Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 21:09 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,150 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001104659-21-019794 · tm213966-3_4seq1.xml · derivative · entry 6 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,150 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each six-month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 21:09 UTC |
Pellizzari Christine AChief Legal Officer
|
SaleCommon Stock | 15,150 | $45.00 | $681,750.00 |
DisclosureSEC source: 0001104659-21-019794 · tm213966-3_4seq1.xml · nonDerivative · entry 4 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,721 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 15,150 shares sold at prices ranging from $44.75 to $45.44 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 21:09 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionCommon Stock | 15,150 | $10.85 | $164,377.50 |
DisclosureSEC source: 0001104659-21-019794 · tm213966-3_4seq1.xml · nonDerivative · entry 3 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 21:09 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,400 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001104659-21-019794 · tm213966-3_4seq1.xml · derivative · entry 5 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,150 Underlying: Common Stock · 6,400 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each six-month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 21:09 UTC |
Pellizzari Christine AChief Legal Officer
|
SaleCommon Stock | 6,400 | $43.95 | $281,280.00 |
DisclosureSEC source: 0001104659-21-019794 · tm213966-3_4seq1.xml · nonDerivative · entry 2 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,721 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 6,400 shares sold at prices ranging from $43.75 to $44.15 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 21:09 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionCommon Stock | 6,400 | $10.85 | $69,440.00 |
DisclosureSEC source: 0001104659-21-019794 · tm213966-3_4seq1.xml · nonDerivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 21:17 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,600 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · derivative · entry 9 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,550 Underlying: Common Stock · 2,600 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each six-month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 21:17 UTC |
Pellizzari Christine AChief Legal Officer
|
SaleCommon Stock | 2,600 | $44.04 | $114,504.00 |
DisclosureSEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · nonDerivative · entry 6 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,721 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 2,600 shares sold at prices ranging from $43.75 to $44.23 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 21:17 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionCommon Stock | 2,600 | $10.85 | $28,210.00 |
DisclosureSEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · nonDerivative · entry 5 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 21:17 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · derivative · entry 8 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,150 Underlying: Common Stock · 6,000 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each six-month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 21:17 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · derivative · entry 7 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,150 Underlying: Common Stock · 15,000 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each six-month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 21:17 UTC |
Pellizzari Christine AChief Legal Officer
|
SaleCommon Stock | 6,000 | $43.84 | $263,040.00 |
DisclosureSEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · nonDerivative · entry 4 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,721 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 6,000 shares sold at prices ranging from $43.75 to $43.94 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 21:17 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionCommon Stock | 6,000 | $10.85 | $65,100.00 |
DisclosureSEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · nonDerivative · entry 3 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 21:17 UTC |
Pellizzari Christine AChief Legal Officer
|
SaleCommon Stock | 15,000 | $42.95 | $644,250.00 |
DisclosureSEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · nonDerivative · entry 2 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,721 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 15,000 shares sold at prices ranging from $42.75 to $43.58 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 21:17 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionCommon Stock | 15,000 | $10.85 | $162,750.00 |
DisclosureSEC source: 0001104659-21-008179 · tm213966-2_4seq1.xml · nonDerivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 21, 2021 Filed Jan 22, 2021 21:49 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · derivative · entry 9 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,150 Underlying: Common Stock · 10,000 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 21, 2021 Filed Jan 22, 2021 21:49 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · derivative · entry 8 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,150 Underlying: Common Stock · 10,000 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 21, 2021 Filed Jan 22, 2021 21:49 UTC |
Pellizzari Christine AChief Legal Officer
|
SaleCommon Stock | 10,000 | $41.98 | $419,800.00 |
DisclosureSEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · nonDerivative · entry 6 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,721 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 10,000 shares sold at prices ranging from $41.75 to $42.19 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 21, 2021 Filed Jan 22, 2021 21:49 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionCommon Stock | 10,000 | $10.85 | $108,500.00 |
DisclosureSEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · nonDerivative · entry 5 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 21, 2021 Filed Jan 22, 2021 21:49 UTC |
Pellizzari Christine AChief Legal Officer
|
SaleCommon Stock | 10,000 | $41.05 | $410,500.00 |
DisclosureSEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · nonDerivative · entry 4 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,721 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 10,000 shares sold at prices ranging from $40.75 to $41.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 21, 2021 Filed Jan 22, 2021 21:49 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionCommon Stock | 10,000 | $10.85 | $108,500.00 |
DisclosureSEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · nonDerivative · entry 3 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 21, 2021 Filed May 14, 2021 20:18 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 184 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 5 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Melvin Sharoky C/F Sophie C. Wink UTMA/FL Disclosed balance after: 184 F2 · kind: The reported transactions involved a gift of securities by the Reporting Person to an investment account, Melvin Sharoky C/F Sophie C. Wink UTMA/FL, for the benefit of the Reporting Person's granddaughter. The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL. Read SEC document |
| January 21, 2021 Filed May 14, 2021 20:18 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 184 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 4 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,318 F2 · kind: The reported transactions involved a gift of securities by the Reporting Person to an investment account, Melvin Sharoky C/F Sophie C. Wink UTMA/FL, for the benefit of the Reporting Person's granddaughter. The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL. Read SEC document |
| January 21, 2021 Filed May 14, 2021 20:18 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 847 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 3 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 847 F1 · kind: The reported transactions involved a gift of securities by the Reporting Person to his spouse. Read SEC document |
| January 21, 2021 Filed May 14, 2021 20:18 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 847 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 2 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,502 F1 · kind: The reported transactions involved a gift of securities by the Reporting Person to his spouse. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:49 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · derivative · entry 7 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,150 Underlying: Common Stock · 10,000 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:49 UTC |
Pellizzari Christine AChief Legal Officer
|
SaleCommon Stock | 10,000 | $39.87 | $398,700.00 |
DisclosureSEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · nonDerivative · entry 2 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,721 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 10,000 shares sold at prices ranging from $39.75 to $40.08 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:49 UTC |
Pellizzari Christine AChief Legal Officer
|
Exercise / conversionCommon Stock | 10,000 | $10.85 | $108,500.00 |
DisclosureSEC source: 0001104659-21-006698 · tm213966-1_4seq1.xml · nonDerivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 12, 2021 Filed May 14, 2021 20:18 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 2,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 1 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,349 Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:40 UTC |
Bonstein SaraChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 45,600 | $0.00 Strike: $34.03 | $0.00 |
DisclosureSEC source: 0001104659-21-002513 · tm211774-13_4seq1.xml · derivative · entry 2 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,600 Underlying: Common Stock · 45,600 shares Expires 2031-01-07 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:40 UTC |
Bonstein SaraChief Financial Officer
|
GrantCommon Stock | 9,183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-002513 · tm211774-13_4seq1.xml · nonDerivative · entry 1 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,183 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:42 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 54,720 | $0.00 Strike: $34.03 | $0.00 |
DisclosureSEC source: 0001104659-21-002514 · tm211774-14_4seq1.xml · derivative · entry 2 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,720 Underlying: Common Stock · 54,720 shares Expires 2031-01-07 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:42 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantCommon Stock | 11,019 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-002514 · tm211774-14_4seq1.xml · nonDerivative · entry 1 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,596 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:40 UTC |
Adsett RogerChief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 54,720 | $0.00 Strike: $34.03 | $0.00 |
DisclosureSEC source: 0001104659-21-002512 · tm211774-12_4seq1.xml · derivative · entry 2 Adsett Roger · CIK 0001685904 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,720 Underlying: Common Stock · 54,720 shares Expires 2031-01-07 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:40 UTC |
Adsett RogerChief Commercial Officer
|
GrantCommon Stock | 11,019 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-002512 · tm211774-12_4seq1.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,552 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:38 UTC |
Pellizzari Christine AChief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 45,600 | $0.00 Strike: $34.03 | $0.00 |
DisclosureSEC source: 0001104659-21-002508 · tm211774-10_4seq1.xml · derivative · entry 2 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,600 Underlying: Common Stock · 45,600 shares Expires 2031-01-07 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:38 UTC |
Pellizzari Christine AChief Legal Officer
|
GrantCommon Stock | 9,183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-002508 · tm211774-10_4seq1.xml · nonDerivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,721 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:39 UTC |
Lewis WilliamDirector · Chair & CEO
|
GrantStock Option (right to buy) · Derivative | 109,440 | $0.00 Strike: $34.03 | $0.00 |
DisclosureSEC source: 0001104659-21-002510 · tm211774-11_4seq1.xml · derivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,440 Underlying: Common Stock · 109,440 shares Expires 2031-01-07 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:39 UTC |
Lewis WilliamDirector · Chair & CEO
|
GrantCommon Stock | 22,039 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-002510 · tm211774-11_4seq1.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,608 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:38 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantStock Option (right to buy) · Derivative | 36,480 | $0.00 Strike: $34.03 | $0.00 |
DisclosureSEC source: 0001104659-21-002506 · tm211774-9_4seq1.xml · derivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,480 Underlying: Common Stock · 36,480 shares Expires 2031-01-07 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:38 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantCommon Stock | 7,346 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-002506 · tm211774-9_4seq1.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,920 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:37 UTC |
SORIANO JOHNChief Compliance Officer
|
GrantStock Option (right to buy) · Derivative | 27,360 | $0.00 Strike: $34.03 | $0.00 |
DisclosureSEC source: 0001104659-21-002505 · tm211774-8_4seq1.xml · derivative · entry 2 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,360 Underlying: Common Stock · 27,360 shares Expires 2031-01-07 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:37 UTC |
SORIANO JOHNChief Compliance Officer
|
GrantCommon Stock | 5,509 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-002505 · tm211774-8_4seq1.xml · nonDerivative · entry 1 SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,773 F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:14 UTC |
Lewis WilliamChair & CEO
|
Tax withholdingCommon Stock | 2,963 | $33.42 | $99,023.46 |
DisclosureSEC source: 0001104659-21-001607 · tm211774d6_4.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,569 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:13 UTC |
Adsett RogerChief Commercial Officer
|
Tax withholdingCommon Stock | 1,223 | $33.42 | $40,872.66 |
DisclosureSEC source: 0001104659-21-001605 · tm211774d4_4seq1.xml · nonDerivative · entry 3 Adsett Roger · CIK 0001685904 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,533 F2 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:12 UTC |
Pellizzari Christine AChief Legal Officer
|
Tax withholdingCommon Stock | 650 | $33.42 | $21,723.00 |
DisclosureSEC source: 0001104659-21-001604 · tm211774d3_4seq1.xml · nonDerivative · entry 2 Pellizzari Christine A · CIK 0001127430 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,538 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:12 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
Tax withholdingCommon Stock | 910 | $33.42 | $30,412.20 |
DisclosureSEC source: 0001104659-21-001602 · tm211774-2_4seq1.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,574 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:11 UTC |
Lewis WilliamDirector · Chair & CEO
|
OtherStock Option (right to buy) · Derivative | 245,950 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 29 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 0 Underlying: Common Stock · 245,950 shares Expires 2026-05-19 F6 · kind: The reported transactions involve transfers of options from the reporting person's spouse to a family trust, ARTICLE 4 TRUST UNDER KATIE PROCTER DYNASTY TRUST, of which the reporting person is a trustee. The reporting person and members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.